Aurobindo Pharma wins U.S. FDA approval for generic asthma inhaler
The product will be manufactured at subsidiary Aurolife Pharma’s Raleigh facility in North Carolina and expected to be launched in upcoming quarters.
· 9/15/2026, 3:08:48 PM· 2 min read
The product will be manufactured at subsidiary Aurolife Pharma’s Raleigh facility in North Carolina and expected to be launched in upcoming quarters.
Read original story →Related stories
business
Flipkart creates 2.5 lakh festive-season jobs, 75,000 for first-time entrants
business
U.S. FDA issues observation to Aurobindo Pharma arm’s API unit
business
August retail inflation raises chances of RBI rate hike in October, say economists
business